1. Home
  2. DGII vs NVAX Comparison

DGII vs NVAX Comparison

Compare DGII & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGII
  • NVAX
  • Stock Information
  • Founded
  • DGII 1985
  • NVAX 1987
  • Country
  • DGII United States
  • NVAX United States
  • Employees
  • DGII N/A
  • NVAX N/A
  • Industry
  • DGII Computer peripheral equipment
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DGII Technology
  • NVAX Health Care
  • Exchange
  • DGII Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • DGII 1.3B
  • NVAX 1.3B
  • IPO Year
  • DGII N/A
  • NVAX 1995
  • Fundamental
  • Price
  • DGII $31.14
  • NVAX $6.56
  • Analyst Decision
  • DGII Hold
  • NVAX Buy
  • Analyst Count
  • DGII 3
  • NVAX 6
  • Target Price
  • DGII $35.67
  • NVAX $15.33
  • AVG Volume (30 Days)
  • DGII 160.9K
  • NVAX 5.1M
  • Earning Date
  • DGII 08-06-2025
  • NVAX 08-06-2025
  • Dividend Yield
  • DGII N/A
  • NVAX N/A
  • EPS Growth
  • DGII 196.64
  • NVAX N/A
  • EPS
  • DGII 1.13
  • NVAX 2.97
  • Revenue
  • DGII $418,624,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • DGII $1.81
  • NVAX $52.02
  • Revenue Next Year
  • DGII $4.34
  • NVAX N/A
  • P/E Ratio
  • DGII $27.61
  • NVAX $2.21
  • Revenue Growth
  • DGII N/A
  • NVAX 25.92
  • 52 Week Low
  • DGII $20.17
  • NVAX $5.01
  • 52 Week High
  • DGII $37.07
  • NVAX $15.22
  • Technical
  • Relative Strength Index (RSI)
  • DGII 33.09
  • NVAX 40.82
  • Support Level
  • DGII $33.01
  • NVAX $6.93
  • Resistance Level
  • DGII $34.83
  • NVAX $8.46
  • Average True Range (ATR)
  • DGII 0.93
  • NVAX 0.34
  • MACD
  • DGII -0.23
  • NVAX -0.08
  • Stochastic Oscillator
  • DGII 5.87
  • NVAX 9.52

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: